Tirzepatide · Cash pay · 2026
Tirzepatide is the molecule in Zepbound and Mounjaro. This board lists the 25 lowest compounded tirzepatide recurring prices without a prepaid multi-month term, each read from the provider's own site.
The short answer
The lowest average monthly budget is Teleios Health at $99/month on average; the 25 cheapest run to $169. First-month teasers, prepaid plans and fee-only rows are left out. CoreAge Rx is a featured partner; providers we work with may appear first, and every row prints its actual charge and billing unit. Weekly cycles are converted using 52 weeks ÷ 12 months for comparison.
25 of 174 providers. CoreAge Rx is a featured partner; providers we work with may appear first. The Metabolic-Fit Score is printed on every row so you can check it.
CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
Compounded semaglutide at $99 a month and tirzepatide at $149, month to month and the same price at every dose, plus a separate microdose line for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prepaying for a year brings it to $89 and $139 a month, and the first-order discount of up to $140 is promotional.
Compounded semaglutide at $99 a month and tirzepatide at $149, month to month, one price at every dose that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. The $69 and $119 on its homepage are the 12-month prepay rates, billed once up front with no refund for unused months, and they sit under a live countdown clock with a lock-for-life promise that is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.
A low-entry, all-in compounded program with both molecules, one price at every dose and a clean cancel-anytime policy — appealing, though the 'from' price isn't explained and the outcome claims are unverified marketing.
Teleios advertises either compounded semaglutide or tirzepatide from $99 monthly, including medication, consultations and shipping. Care runs through the named Lion MD network, and state-specific availability needs confirmation.
LumiMeds carries a 2025 FDA warning letter over how it described its compounded medication. Semaglutide: $89/mo advertised flat rate; tirzepatide: $125/mo advertised flat rate. The promotion promises a price lock, but terms reserve price changes, restrict mid-term cancellation and apply a $100 deduction to applicable refunds.
Eighty-six dollars a month for compounded semaglutide is among the lowest figures on this page, and $125 for tirzepatide is genuinely cheap for the dual agonist. What sits directly beneath those numbers is the problem. Each card carries an average: "Average 15-20% body weight loss" on the semaglutide, "Average 20-25%" on the tirzepatide. The upper end of that second range is higher than tirzepatide achieved at its maximum dose in its own registrational trial, and these are compounded products that were never in one.
Mondae lists semaglutide at $87 a month and tirzepatide at $126 with a one-month plan. Its lower $69 and $114 averages require six-month prepayments of $414 and $684.
Its recorded operator, Trinity HealthCare Supply LLC dba altRx, received FDA warning letter 728236 concerning another website. NextMeds’ current catalog lists semaglutide at $79 a month and tirzepatide at $129, with the same renewal prices. Its $49 headline requires the $588 annual semaglutide plan.
One of the few genuinely flat prices on this list — $99/mo semaglutide and $134/mo tirzepatide that do not rise as your dose does, in all fifty states — from a company that never names itself anywhere on its own website.
"As low as $83/mo, all-in" is $999 paid up front, divided by twelve. Month to month is $119. The honest thing to say next is that $119 is still cheaper than most providers we review, so the problem is the advertised number rather than the price behind it.
Semaglutide: $126/mo monthly; $107.10/mo quarterly; tirzepatide: $144/mo monthly; $122.40/mo quarterly. Quarterly totals are $321.30 and $367.20; advertised prices include the listed care and shipping fees and exclude California.
A flat-priced provider naming several individual physicians (including a specifically-credited Medical Director) — $125/mo semaglutide, $145/mo tirzepatide as currently displayed — though the site's own strikethrough pricing presentation leaves it unresolved whether that's a standing rate or a promotional one, so confirm at signup.
Advertised dose-flat monthly plans are $99 for semaglutide and $149 for tirzepatide, with care, medication and shipping included. Confirm the selected supply and plan. Cancellation stops future renewal; after prescribing, payments including unused prepaid months are nonrefundable under the stated policy.
One of the lowest listed prices for compounded GLP-1s — $89 a month for semaglutide and $149 for tirzepatide, the same at every dose, with the visit, supplies and shipping included — from a company that received an FDA warning letter in June 2026 and treats every payment as final. Cancellation needs 72 hours' notice, and a documented trinitymeds trademark connection deserves attention.
Semaglutide: $129/mo monthly ($99/mo on a 3-month pack); tirzepatide: $149/mo monthly ($119/mo on a 3-month pack). Three-month packs cost $297 for semaglutide or $357 for tirzepatide upfront, with transfer patients advised to confirm eligibility and pricing.
The lowest published prices in this group, and shown the plainest way: an open storefront with six figures on it, no account and no intake needed. Microdose semaglutide is $99 a month, microdose tirzepatide $119, standard semaglutide $129 and standard tirzepatide $149, each sold once weekly with vitamin B6, with needle-free oral drops of both molecules at the microdose price. The microdose tiers genuinely cost less than the standard ones, which is not true of every seller here. Two things deserve weight against that. The oral drops are sold with no published evidence for the route, and milligrams under the tongue are not interchangeable with milligrams injected. And the same page advertises retatrutide, labeled "GLP-3", as a product coming soon, alongside orforglipron and two oral tablets — retatrutide is investigational and approved for nothing, and "GLP-3" is a nickname rather than a drug class. No state list is published and no dispensing pharmacy is named.
One price for either molecule — $149.97 a month, $134.99 on six months, $112.50 on twelve — and the arithmetic is exact. Then the same page tells you its plans start at $249.97, which is a hundred dollars above the most expensive thing it sells. That figure turns out to be the interesting part: the identical orphan number appears on Next Vial, where it contradicts that site's prices too.
Semaglutide: From $79.99/mo; tirzepatide: From $149.99/mo. These are advertised starting amounts; dose, plan duration and renewal conditions need confirmation.
Semaglutide: From $125 per four weekly injections; rises with dose; tirzepatide: From $145 per four weekly injections; rises with dose. Cost rises with dose; the $99 SDV sticker can cover a single injection and must not be read as a full month.
Pepti publishes semaglutide prices of $99–$199 a month and tirzepatide prices of $159–$319, depending on dose. Medication, physician care and shipping are included without a separate membership fee.
WePeptideRx advertises semaglutide from $149 and tirzepatide from $159 per 30-day supply. These discounted starting prices include the provider consultation and priority shipping; higher-dose prices need confirmation.
Semaglutide: $119/mo; tirzepatide: Starting at $159/mo. Both are starting prices; the final dose, plan length and renewal total need confirmation.
Two things here are genuinely unusual. Tirzepatide costs the same as semaglutide — both from $169 a month — where nearly every other seller charges a premium of fifty to a hundred dollars for the dual-agonist. And Lighter You names four compounding pharmacies in full, with street addresses and phone numbers: RedRock, Health Warehouse, Precision Compounding and Triad Rx. Most providers we review name none. Coverage is all fifty states plus Washington, D.C.
| # | Provider | Tirz from | Score | |
|---|---|---|---|---|
| 1 | CoreAge Rx | $129/mo | See review | 86 · B |
| 2 | Strut Health | $149/mo | See review | 80 · B− |
| 3 | Lttl | $149/mo | All 50 states | 56 · C |
| 4 | SnagRx | $149/mo | See review | 56 · C |
| 5 | yourEra | $159/mo | See review | 76 · C |
| 6 | Teleios Health | $99/mo | See review | 47 · C |
| 7 | LumiMeds | $125/mo | All 50 states | 49 · C |
| 8 | Ozari Health | $125/mo | See review | 33 · C |
| 9 | Mondae | $126/mo | All 50 states | 46 · C |
| 10 | NextMeds | $129/mo | All 50 states | 39 · C |
| 11 | FitFlow | $134/mo | All 50 states | 42 · C |
| 12 | PreventiveMD | $139/mo | See review | 52 · C |
| 13 | Healthicare | $144/mo | 44 states | 50 · C |
| 14 | Citizen Meds | $145/mo | See review | 43 · C |
| 15 | Harbor | $149/mo | See review | 63 · C |
| 16 | altRx | $149/mo | All 50 states | 56 · C |
| 17 | Brightmeds | $149/mo | See review | 53 · C |
| 18 | Bayan Health | $149/mo | See review | 37 · C |
| 19 | LevelUp Rx | $149.97/mo | See review | 49 · C |
| 20 | Factor Health MD | $149.99/mo | See review | 40 · C |
| 21 | VitaStir | $145/4 wk | See review | 35 · C |
| 22 | Pepti | $159/mo | 36 states | 58 · C |
| 23 | WePeptideRx | $159/mo | 48 states | 49 · C |
| 24 | Pomegranate Health | $159/mo | See review | 46 · C |
| 25 | Lighter You | $169/mo | All 50 states | 43 · C |
Of the 174 providers that publish a recurring compounded tirzepatide price, the lowest is Teleios Health at an average $99 per month. On that monthly-average basis, the 25 lowest run from $99 to $169, and half sit at or under $149. An unusually low figure is worth confirming at the dose you will stay on before you pay.
Zepbound and Mounjaro are Eli Lilly's FDA-approved brand products. Compounded tirzepatide is prepared by a pharmacy and is not FDA-approved, which is why it sells for a fraction of the brand price. Since the FDA declared the tirzepatide shortage over in late 2024, compounders generally need a patient-specific reason to prepare it, so many programs describe a personalized dose or an added ingredient.
It depends on the program. Of the 25 here, 15 say one price covers every dose and 4 say the price rises as the dose climbs; the rest do not say. Tirzepatide usually starts at 2.5 mg a week and steps up every four weeks, so price the dose you expect to stay on, not the starter.
The Zepbound label includes a milk-transfer study but no data on infant effects or milk production, and asks you and your clinician to weigh the benefits of breastfeeding against your need for the drug. Compounded versions carry no label of their own. Tirzepatide is not used in pregnancy, and it can make oral birth control less reliable after a start or a dose increase.
Rankings reflect our published methodology. This page is informational and not medical advice; compounded medications are not FDA-approved brand products, and GLP-1 medicines are not used in pregnancy or while trying to conceive. See our medical disclaimer. Some links here earn us a referral fee, walled off from the score — read our funding disclosure.
Keep exploring
Each board answers a different question a mother brings to GLP-1 care.